STOCK TITAN

PEN Form 144: Insider Notice to Sell 2,000 Common Shares via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Penumbra, Inc. submitted a Form 144 reporting a proposed sale of 2,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $500,000. The filing lists 38,999,129 shares outstanding and specifies the approximate sale date as 08/13/2025 on the NYSE. The notice shows no securities sold in the past three months under the provided "Nothing to Report" entry.

The 2,000 shares to be sold match earlier restricted stock acquisitions recorded in the filing: 338 shares on 12/16/2020, 612 on 11/15/2022, 726 on 12/16/2022, and 324 on 03/15/2024, totaling 2,000 shares. The filer makes the required representation regarding material nonpublic information and mentions Rule 10b5-1 instructions if applicable.

Positive

  • Proposed sale fully specified: 2,000 common shares with $500,000 aggregate market value and broker identified as Morgan Stanley Smith Barney LLC
  • Acquisition history disclosed: all 2,000 shares were recorded as restricted stock on documented dates totaling the amount offered for sale
  • No recent sales reported: the filing shows "Nothing to Report" for sales during the past three months

Negative

  • Issuer contact fields are blank in the provided excerpt: key issuer address/phone/name entries are not populated in this content

Insights

Small, transparent insider sale disclosed; not likely market-moving.

The Form 144 notifies the market of a planned sale of 2,000 common shares via Morgan Stanley Smith Barney at an aggregate value of $500,000. The filing documents that these shares were acquired as restricted stock across four grant dates and that no sales occurred in the prior three months. Given the listed 38,999,129 shares outstanding, the position disclosed is small relative to the share base and therefore unlikely to be materially impactful to valuation.

Form 144 provides required disclosure and acquisition provenance; procedural completeness is mixed.

The filing supplies broker details and acquisition dates showing the securities were granted as restricted stock, which is relevant for Rule 144 eligibility. The filer also includes the statutory representation about nonpublic material information and notes Rule 10b5-1 plan consideration. However, several issuer contact fields in the excerpt are not populated, which reduces the filing's standalone completeness for third-party verification.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does Penumbra (PEN) plan to sell under this Form 144?

2,000 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $500,000

When is the approximate date of the proposed sale listed on the Form 144?

08/13/2025 is shown as the approximate date of sale

On which exchange will the shares be sold?

NYSE is listed as the securities exchange for the proposed sale

How were the 2,000 shares acquired according to the filing?

They were acquired as restricted stock: 338 on 12/16/2020, 612 on 11/15/2022, 726 on 12/16/2022, and 324 on 03/15/2024

Were any securities sold by the filer in the past three months?

Nothing to Report is entered for securities sold during the past three months
Penumbra Inc

NYSE:PEN

View PEN Stock Overview

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

13.19B
37.87M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA